Jack D B, Kendall M J, Laugher S J, Smith S R
Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):185S-190S. doi: 10.1111/j.1365-2125.1985.tb02760.x.
Plasma oxprenolol concentrations were measured in six young healthy female volunteers after single oral dosing with a 16/260 oxprenolol Oros system on three separate occasions. Reproducibility was assessed by comparing individual plasma profiles, areas under the curve, peak concentrations and times to peak. Plasma concentration-time profiles were consistent with an extended duration of drug release from the Oros system. Individual and mean profiles on the three occasions were similar, and no significant differences in mean plasma levels, or derived pharmacokinetic parameters, were detected. The mean amount of drug in eight systems recovered from faeces corresponded to 11% of the dose. Individual amounts were related to the total transit time of the system through the body. The 16/260 Oros system functioned reproducibly within the gastrointestinal tract, and in vivo absorption mirrored in vitro drug release.
在六名年轻健康女性志愿者单次口服16/260奥普洛尔渗透泵控释系统后,于三个不同时间点测定血浆奥普洛尔浓度。通过比较个体血浆浓度曲线、曲线下面积、峰值浓度和达峰时间来评估重现性。血浆浓度-时间曲线与奥普洛尔渗透泵控释系统药物释放的延长时间一致。三个时间点的个体和平均曲线相似,未检测到平均血浆水平或推导的药代动力学参数有显著差异。从粪便中回收的八个系统中的药物平均量相当于剂量的11%。个体药物量与系统在体内的总转运时间有关。16/260奥普洛尔渗透泵控释系统在胃肠道内功能具有重现性,体内吸收反映了体外药物释放情况。